ONCLADEG Trademark

Trademark Overview

On Monday, March 2, 2026, a trademark application was filed for ONCLADEG with the United States Patent and Trademark Office. The USPTO has given the ONCLADEG trademark a serial number of 99679088. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, April 2, 2026. This trademark is owned by BeOne Medicines I GmbH. The ONCLADEG trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemicopharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs for medical use being medicines for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical use, namely, for the treatment and prevention of cance...
oncladeg

General Information

Serial Number99679088
Word MarkONCLADEG
Filing DateMonday, March 2, 2026
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, April 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicines for human purposes for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemicopharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs for medical use being medicines for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical use, namely, for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical use, namely, for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; injectable pharmaceuticals for treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude medicines for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biochemical preparations for medical use, namely, the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 2, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeOne Medicines I GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Monday, March 2, 2026NEW APPLICATION ENTERED
Monday, March 2, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 2, 2026APPLICATION FILING RECEIPT MAILED
Thursday, March 19, 2026ASSIGNED TO EXAMINER
Friday, March 20, 2026NON-FINAL ACTION WRITTEN
Friday, March 20, 2026NON-FINAL ACTION E-MAILED
Friday, March 20, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 1, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 1, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 1, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 2, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

oncladeg diseases treatment rheumatoid arthritis cardiovascular inflammatory infectious autoimmune cancer preparations